Prevalence of renal cell carcinoma: a nation-wide survey in Japan, 2002
- PMID: 17593088
- DOI: 10.1111/j.1442-2042.2007.01739.x
Prevalence of renal cell carcinoma: a nation-wide survey in Japan, 2002
Abstract
Objective: To investigate the incidence of renal cell carcinoma, classified by sex, age group and region in Japan, following a 5-year interval after a previous survey performed in 1997.
Methods: The survey was conducted between the beginning of January 2002 and the end of December 2002. A total of 1288 institutions in all 47 prefectures throughout Japan were requested to register cases.
Results: There were 7405 persons with renal cell carcinoma, consisting of 5063 males and 2342 females. Crude incidence rates were 8.2 and 3.6 per 100 000 population for men and women, respectively. Incidence rates in the Hokkaido region were highest followed by the Shikoku region.
Conclusions: Despite incidence of renal cell carcinoma increasing to 7405 from the 6358 persons in 1997, statistical data reported by the Ministry of Health, Labor and Welfare indicate that rising age-adjusted death rate for this tumor reached a ceiling in the past decade. Early detection may have contributed to this current trend; however, further epidemiological research is required to fully elucidate this.
Similar articles
-
The prevalence of renal cell carcinoma: a nation-wide survey in Japan in 1997.Int J Urol. 2001 Jul;8(7):359-65. doi: 10.1046/j.1442-2042.2001.00314.x. Int J Urol. 2001. PMID: 11442657
-
Collecting duct (Bellini duct) renal cell carcinoma: a nationwide survey in Japan.J Urol. 2006 Jul;176(1):40-3; discussion 43. doi: 10.1016/S0022-5347(06)00502-7. J Urol. 2006. PMID: 16753362
-
Rising incidence of small renal masses: a need to reassess treatment effect.J Natl Cancer Inst. 2006 Sep 20;98(18):1331-4. doi: 10.1093/jnci/djj362. J Natl Cancer Inst. 2006. PMID: 16985252
-
Coincident renal cell carcinoma and nonHodgkin's lymphoma: the M. D. Anderson experience and review of the literature.J Urol. 1998 Mar;159(3):714-7. J Urol. 1998. PMID: 9474132 Review.
-
Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review.Cancer Treat Rev. 2008 May;34(3):193-205. doi: 10.1016/j.ctrv.2007.12.001. Epub 2008 Mar 4. Cancer Treat Rev. 2008. PMID: 18313224 Review.
Cited by
-
Clinico-pathological analysis of renal cell carcinoma demonstrates decreasing tumour grade over a 17-year period.Can Urol Assoc J. 2014 Mar;8(3-4):125-32. doi: 10.5489/cuaj.1721. Can Urol Assoc J. 2014. PMID: 24839483 Free PMC article.
-
Histology is a Prognostic Indicator After Pulmonary Metastasectomy from Renal Cell Carcinoma.World J Surg. 2017 Mar;41(3):771-779. doi: 10.1007/s00268-016-3802-9. World J Surg. 2017. PMID: 27896403
-
Outcomes of curative nephrectomy against renal cell carcinoma based on a central pathological review of 914 specimens from the era of cytokine treatment.Int J Clin Oncol. 2015 Dec;20(6):1161-70. doi: 10.1007/s10147-015-0840-5. Epub 2015 May 16. Int J Clin Oncol. 2015. PMID: 25981949
-
A clinical investigation of recurrence and lost follow-up after renal cell carcinoma surgery: a single-center, long-term, large cohort, retrospective study.Int J Clin Oncol. 2022 Sep;27(9):1467-1476. doi: 10.1007/s10147-022-02204-x. Epub 2022 Jun 29. Int J Clin Oncol. 2022. PMID: 35767079 Review.
-
Protein disulfide isomerase family 6 promotes the imatinib-resistance of renal cell carcinoma by regulation of Wnt3a-Frizzled1 axis.Bioengineered. 2021 Dec;12(2):12157-12166. doi: 10.1080/21655979.2021.2005218. Bioengineered. 2021. PMID: 34781823 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous